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HIGHLIGHTS
• Eighteen EOPD, 21 LOPD and 37 age-matched normal control subjects participated
in the resting state fMRI scans.
• Age at onset of PD modulates the distribution of cerebral regional homogeneity during
resting state.
• Disproportionate putamen alterations are more prominent in PD patients with a
younger age of onset.
Objective: Early-onset Parkinson’s disease (EOPD) is distinct from late-onset PD (LOPD)
as it relates to the clinical profile and response to medication. The objective of current
paper is to investigate whether characteristics of spontaneous brain activity in the resting
state are associated with the age of disease onset.
Methods: We assessed the correlation between neural activity and age-at-onset in a
sample of 39 PD patients (18 EOPD and 21 LOPD) and 37 age-matched normal control
subjects. Regional homogeneity (ReHo) approaches were employed using ANOVA with
two factors: PD and age.
Results: In the comparisons between LOPD and EOPD, EOPD revealed lower ReHo
values in the right putamen and higher ReHo values in the left superior frontal gyrus.
Compared with age-matched control subjects, EOPD exhibited lower ReHo values in
the right putamen and higher ReHo values in the left inferior temporal gyrus; However,
LOPD showed lower ReHo values in the right putamen and left insula. The ReHo values
were negatively correlated with the UPDRS total scores in the right putamen in LOPD,
but a correlation between the ReHo value and UPDRS score was not detected in EOPD.
Conclusions: Our findings support the notion that age at onset is associated with
the distribution of cerebral regional homogeneity in the resting state and suggest that
disproportionate putamen alterations are more prominent in patients with a younger age
of onset.
Keywords: early-onset Parkinson’s disease, late-onset Parkinson’s disease, regional homogeneity, putamen,
resting-state functional MRI
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INTRODUCTION
Early-onset Parkinson’s disease (EOPD) usually refers to the
form of PD in which the first symptoms appear before 40 years
of age, but some studies consider a disease onset of up to
50 years of age to be EOPD (Schrag and Schott, 2006). The
prevalence of early-onset PD is approximately 5–10% of the
entire PD patient population (Quinn et al., 1987). EOPD had
been long contrasted with the late-onset form of the disease
(LOPD) until they became united under the same eponym (Spica
et al., 2013). Although these two forms of PD now refer to a single
disease, previous studies have reported clinical and neuroimaging
differences between EOPD and LOPD. EOPD tends to have
slower disease progression than LOPD, particularly with regard
to falls and freezing (Inzelberg et al., 2004; Alves et al., 2005).
Schrag et al. have noted that EOPD is associated with less
cognitive decline (Schrag et al., 1998), at least until patients reach
a more advanced age, and EOPD patients experience poorer
social adjustment and higher rates of depression and anxiety
(Schrag and Schott, 2006; Mehanna et al., 2014). In contrast,
more patients with EOPD have earlier motor complications, such
as dyskinesias, dystonia, and motor fluctuations (Schrag et al.,
1998). With respect to treatment, EOPD patients have a better
medication response to levodopa (Ribeiro et al., 2009). Moreover,
Kondo et al. have suggested that the dopamine agonist therapies
that are more commonly used in EOPD might reduce dopamine
transporter (DAT) loss during PD disease progression (Kondo,
2002). The pathophysiological mechanisms that differentiate
EOPD and LOPDdisease progression are not yet clear (Shih et al.,
2007).
Little is known about how these two clinical subtypes differ at
the neural level. The results of structural imaging in EOPD are
typically normal (Schrag and Schott, 2006). Functional imaging
with single-photon emission computed tomography (SPECT)
in EOPD reveals similar findings to that in classic PD with
presynaptic dysfunction of nigrostriatal dopaminergic neurons
(Thobois et al., 2003). However, positron emission tomography
(PET) indicates that the age of disease onset might be one of
the factors related to the heterogeneity in patterns of regional
metabolism (Shih et al., 2007; de la Fuente-Fernández et al.,
2011). Compensatory up-regulatory functions of postsynaptic
receptorsmaymodify disease severity and the degrees of themain
clinical symptoms of EOPD observed by PET (Nagasawa et al.,
1996). An MRI study of brain iron has highlighted that there
is dysregulation of iron metabolism in the substantia nigra that
differs in early- vs. late-onset PD (Bartzokis et al., 1999). Taken
together, these findings suggest that the topographic distributions
of pathological changes differ in EOPD and LOPD. However, the
available literature on this topic lacks clarity because adjustments
for multiple types of testing are insufficient, direct comparisons
between EOPD and LOPD have not been performed, an a priori
hypothesis has not been established, and different image analysis
techniques have been used.
In the present study, we used regional homogeneity (ReHo)
to detect different patterns of abnormal neural activity in early-
and late-onset PD patients compared with age-matched normal
controls. We hypothesized that a different level of regional brain
dysfunction would be detected in the EOPD group compared to
the LOPD group, even at similar disease stages.
MATERIALS AND METHODS
We studied 39 patients with PD (16 males, 23 females; mean
age 59.5) and 37 healthy, age- and gender-matched controls
(mean age 59.7). All patients met the following criteria: (1) All
fulfilled the UK Parkinson’s Disease Society Brain Bank criteria
for idiopathic PD; (2) The age of onset was either before or after
50 years [a commonly used cut-off age point to divide EOPD
from LOPD (Schrag and Schott, 2006)]; (3) a H&Y stage equal
to or less than 3.0 while in an “off” state; (4) The Mini-Mental
State Examination (MMSE) scores were higher than 24; (5) The
was no evidence of primary medical illness, psychiatric illness
or neurological illness; (6) The T2-weighted MRI images did
not exhibit gross white matter or gray matter alterations; (7) To
exclude the confounding factor of a long illness duration and
motor complications, the illness duration was less than 10 years
and without motor complications; (8) To avoid disturbances to
the fMRI signal, all patients had, at most, a mild tremor.
Neurological and psychiatric evaluations were conducted
during the “off” medication state (wherein subjects refrained
from taking their PD medications for at least 12 h prior to
assessment) and included the Hoehn and Yahr (H&Y) scale,
the unified Parkinson’s disease rating total scale (UPDRS),
the UPDRS Part III, the MMSE, and the HAMD. All
neuropsychological evaluations and RS-fMRI scans (for ReHo
and functional connectivity analyses) were implemented around
the same time.
Thirty-seven age- and gender-matched normal controls were
recruited. They were either younger than 50 years (19 persons)
or older than 50 years (18 persons). All normal control subjects
had a normal neurological status and were without a history of
serious medical or neuropsychiatric disease or a family history of
psychiatric or neurological disease among first-degree relatives.
Our research protocol complied with the guidelines for the
conduct of research involving human subjects as established by
the National Institutes of Health and the Committee on Human
Research at Chongqing Medical University in China.
Data Acquisition
All MR images were acquired using a GE Signa HDxt 3.0T
scanner (General Electric Medical Systems, USA) with a standard
8-channel head coil. Foam padding was used to minimize
head motion. Apart from this, no other special methods
were employed to prevent head movement. During RS-fMRI
acquisition, all subjects were instructed to relax and to keep still
with eyes closed but to remain awake (confirmed with post-scan
debriefing).
RS-fMRI data were acquired using an echo-planar image (EPI)
pulse sequence and the following parameters: 33 axial slices;
thickness/gap= 4.0/0mm; matrix= 64× 64; TR= 2000ms; TE
= 40ms; flip angle = 90◦; and FOV = 240 × 240mm. A total of
240 time points were obtained in 8min. High-resolution 3D-T1
images were also acquired (repetition time [TR] = 8.3ms; echo
Frontiers in Aging Neuroscience | www.frontiersin.org 2 July 2016 | Volume 8 | Article 165
Sheng et al. Onset Age of Parkinson’s Disease
time [TE] = 3.3ms; flip angle = 15◦; thickness/gap = 1.0/0mm;
field of view [FOV]= 240× 240mm; matrix= 256× 192).
Data Processing
The data were analyzed using Statistical Parametric Mapping
(SPM8) (http://www.fil.ion.ucl.ac.uk), Resting State fMRI Data
Analysis Toolkit (REST) software on version 1.8 (Song et al.,
2011) (http://www.restfmri.net), and the Data Processing
Assistant for Resting-State fMRI–Advanced on version 2.1
(DPARSFA; http://www.restfmri.net) with Matlab version
7.10.0.499 (Machizawa et al., 2010).
The first 10 time points were discarded to account for
scanner calibration and the acclimatization of subjects to the
scanning environment, after which, 230 time points remained.
The following preprocessing procedures were included: Time
alignment across slices, motion correction, within-subject
registration between T1 and EPI images, T1 segmentation,
and the application of normalization parameters to the BOLD
fMRI datasets to register them to Montreal Neurologic Institute
(MNI) space, with voxels resampled at 3 × 3 × 3mm. Linear
trends were removed, and a temporal filter (0.01 < f <
0.08 Hz) was applied to eliminate low-frequency drift and
physiological high-frequency noise. The high-resolution 3D-
T1 images were segmented into gray matter (GM), whiter
matter (WM), and cerebrospinal fluid (CSF) by using unified
segmentation (Ashburner and Friston, 2005) and were then
normalized to MNI space. Head motion can influence on result
even though traditional realignment was performed (Power et al.,
2012; Satterthwaite et al., 2013). All images were realigned to
the first image to account for head motion. All subject had a
maximum displacement in any of the cardinal directions (x, y,
z) less than 2mm, or a maximum spin (x, y, z) less than 2◦. In
addition, following previous studies (Van Dijk et al., 2012), the
mean relative displacement was used to measure subjects’ head
motion in scanner.
ReHo Analysis
Individual ReHo maps were generated for each subject using
REST software; Kendall’s coefficient of concordance (KCC) was
calculated at each voxel to establish similarities between the time
series of each specific voxel and its 26 neighboring voxels within a
whole-brainmask (this mask is provided by DPARSFA, excluding
non-brain areas). The KCC value was calculated to this voxel, and
an individual KCC map was obtained for each subject. To reduce
the influence of individual variations in the KCC value, ReHo
map normalizations were performed by dividing the KCC among
each voxel by the averaged KCC of the whole brain (using the
same whole brain mask). The calibrated ReHo maps were further
smoothed using an isotropic Gaussian kernel with a full-width at
half maximum (FWNM) of 4× 4× 4mm.
Statistical Analysis
Differences of age and MMSE scores among the four groups
were compared by using analysis of variance (ANOVA) with two
factors: Parkinson’s disease and age of onset. The Pearson χ2-test
was applied to compare gender differences. Student’s t-test was
employed to compare illness duration, UPDRS scores and H&Y
stages between the two patient groups.
To identify the ReHo maps between groups, a full factorial
design was used that automatically models interactions between
the factors in SPM8. We used diagnosis and age as factors
with independent levels with unequal variance. To test group
differences post-hoc, we used separate 2-sample t-tests to
compare early-onset PD patients with young control subjects,
and late-onset PD patients with old control subjects. Finally, the
threshold for statistical significance in ReHo post-hoc analysis was
set to p < 0.01 with family wise error (FWE) correction at the
voxel level.
Correlation between Clinical Data and
ReHo
To examine the association of ReHo abnormalities with the
clinical data of the PD patients, we also performed a voxel-
based correlative analysis between mean ReHo values extracted
from the regions with significant group differences of the clusters
(EOPD vs. LOPD), patient illness durations and total UPDRS
scores. For correlation analysis we used an uncorrected threshold
of p< 0.001.
RESULTS
Demographic and Clinical Data
Demographic information, illness duration, disease stage,
UPDRS scores, and medications are summarized in Table 1 for
all patients (18 EOPD and 21 LOPD) and control subjects (19
young NCs, and 18 old NCs). There was a significant difference
in age among the four groups (ANOVA, P < 0.01). The young
and old NCs were matched with EOPD and LOPD patients in age
(t-tests EOPD P= 0.39; LOPD P= 0.21) and gender (Chi-square
test EOPD P = 0.62; LOPD P = 0.50). There was no difference
between the EOPD and LOPD group in terms of the duration
of PD, the UPDRS total score, the UPDRS Part III score, the
side initially affected, the medication used, or the MMSE score
(two-sample t-tests, P > 0.05).
Head Motion
There was no significant difference in head motion when the
mean head motion was measured and compared between the
four groups using ANOVA (P = 0.21). Therefore, PD patients
and normal controls were similar in head motion characteristics.
ReHo
The full factorial design showed that diagnosis and age affected
the ReHo value patterns. A diagnosis of PD was associated
with an alternative ReHo in the bilateral gyrus rectus, left
caudate nucleus, bilateral putamen, bilateral inferior frontal
gyrus, and bilateral cerebellum (p< 0.05, FWE-corrected). Older
age was associated with an alternative ReHo in the bilateral
superior frontal gyrus orbital part (p < 0.05, corrected by FWE).
Furthermore, there was a significant interaction between age
and diagnosis (p < 0.05, FWE-corrected), showing that with a
younger onset of PD, there was an altered brain ReHo value in the
left superior frontal gyrus, right putamen, right superior frontal
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TABLE 1 | Demographic and clinical data in EOPD/LOPD patients and normal controls.
Group N EOPD Young NC EOPD vs.
controls P-value
LOPD Old NC LOPD vs.
controls P-value
EOPD vs.
LOPD P-value
N (female) 18 (8) 19 (10) 0.62 21 (9) 18 (10) 0.50 0.92
Age (Y) 45.4± 6.07 45.8 ± 3.55 0.39N 63.6±4.84 61.7 ± 9.73 0.21N < 0.001⋆
Disease duration (Y) 3.04± 1.99 NA 3.1±1.78 NA 0.43N
Disease stage(H&Y) 2.03± 0.78 NA 2.0±0.62 NA 0.49N
UPDRS 37.8± 9.86 NA 39.3±10.62 NA 0.3N
UPDRS III 16.94± 5.07 NA 18.61±4.51 NA 0.29N
MMSE 27.8± 1.56 29.2 ± 0.91 0.003N 26.5±2.16 27.2 ± 2.74 0.21N 0.065⋆
HAMD 6.38± 2.06 5.47 ± 1.87 0.089N 6.52±2.81 5.72 ± 2.10 0.17N < 0.001⋆
Side initially affected, R/L 11/7 NA 10/11 NA 0.40•
L-Dopa dose (mg/d) 395.8± 278.7 NA 440.5±187.9 NA 0.28N
No. (%) of patients treated with pramipexole 14 (78) NA 16 (76) NA 0.91•
No. (%) of patients treated with piribedil 9 (50) NA 14 (67) NA 0.29•
NC, Normal control; EOPD, Early-onset Parkinson’s disease patients; LOPD, Late-onset Parkinson’s disease patients.
N: Two sample t-test.
•: Pearson χ2-test.
⋆: ANOVA analysis with two factors.
: Chi-square test.
gyrus, left inferior temporal gyrus, right fusiform, and left insula
when compared to that in late-onset PD patients.
In the post-hoc comparison between early-onset and late-
onset PD patients, we observed that EOPD patients showed a
significant decrease in the ReHo value in the right putamen and
an increase in the ReHo value in the left superior frontal gyrus
(p< 0.01, FWE-corrected; Figure 1A). The ReHo value in EOPD
patients was lower than that in age-matched controls in the right
putamen and higher in left inferior temporal gyrus (p < 0.01,
FWE-corrected; Figure 1B). Compared to older normal controls,
patients with LOPD exhibited decreased ReHo values in the right
putamen and left insula (P < 0.01; FWE-corrected; Figure 1C
and Table 2).
Correlations between ReHo Values and the
Clinical Data
A negative correlation was found between the ReHo values of
the right putamen (x, y, z = 29, 14, 0) and the UPDRS scores
in LOPD patients (r = –0.67, p < 0.01). In LOPD patients, no
significant correlation was discovered between ReHo values and
illness duration. In EOPD patients, no significant correlation
was observed between the ReHo value and UPDRS total scores.
Neither was there a correlation between the ReHo value and
disease duration in the EOPD group (P < 0.01, uncorrected;
Figure 2).
DISCUSSION
The present fMRI study used the ReHo method to investigate
the regional activity alterations in EOPD and LOPD patients
compared with age-matched normal controls in the resting state.
We found different regional activity patterns between EOPD and
LOPD patients. Compared with age-matched normal controls,
EOPD, and LOPD patients showed altered activities mainly in the
basal ganglia. Furthermore, compared to LOPD patients, EOPD
patients exhibited decreased ReHo values in the right putamen
and increased ReHo values in the left superior frontal gyrus
despite having similar disease severity. Additionally, using voxel-
wise correlation analysis, in LOPD patients, we found a negative
correlation between the ReHo value in the right putamen and the
UPDRS total score, but this was not detected in EOPD patients.
In previous studies, RS-fMRI has detected spontaneous
neuronal activity (Biswal et al., 1995) and/or the endogenous or
background neurophysiologic processes of the brain based on
the temporal correlation of spontaneous, blood oxygen level-
dependent (BOLD) fluctuations in low frequencies (<0.08 Hz;
Raichle et al., 2001; Fox and Raichle, 2007). ReHo is a RS-fMRI
analysis method based on a data-driven approach; therefore, it
requires no prior knowledge and has good test-retest reliability
(Zuo et al., 2013). ReHo measures the functional coherence of
a given voxel with its nearest neighbors and evaluate resting-
state brain activities based on the hypothesis that significant
brain activities would more likely occur in clusters than in a
single voxel (Zang et al., 2004). Decreased or increased ReHo
suggests that functional activity in certain regions is poorly or
highly synchronized compared to controls (Su et al., 2015).
ReHo measurement of RS-fMRI has been employed by others
to analyze the similarities of intra-regional time series across the
whole brain of the regional BOLD signal. Few studies have used
whole-brain functional approaches such as regional homogeneity
(ReHo) to investigate the functional differences between EOPD
and LOPD.
The putamen, which has shown decreased ReHo in both types
of PD patients, is one of the important regions associated with
planning and execution of self-initiated movements (François-
Brosseau et al., 2009). Previous studies have demonstrated
that the putamen had lower cerebral blood flow and was
hypoactivated in PD when various movements were performed
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FIGURE 1 | Statistical maps showing the ReHo differences among patients with EOPD or LOPD and normal controls (P < 0.01, FWE corrected). (A)
Compared with LOPD, EOPD showed significantly deceased ReHo values in the right putamen and increased ReHo values in the left superior frontal gyrus. (B)
Compared with younger normal controls, EOPD showed significantly deceased ReHo values in the right putamen and increased in the left inferior temporal gyrus. (C)
Compared with older normal controls, LOPD exhibited decreased ReHo values in the right putamen and left insula. Red and blue denote higher and lower ReHo
values, respectively, and the color bars indicate the T-value from post-hoc analyses between each pair of groups.
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TABLE 2 | Regions showing ReHo differences among the EOPD, LOPD, and NC groups by post-hoc analysis.
Brain region Cluster size MNI T-value
x y z
EOPD < LOPD
Right putamen 99 29 14 0 −4.23
EOPD > LOPD
Left superior frontal gyrus 106 −25 65 10 5.57
EOPD < YOUNG NC
Right putamen 93 28 7 −3 −7.00
EOPD > YOUNG NC
Left inferior temporal gyrus 139 −44 10 −39 5.67
LOPD < OLD NC
Right putamen 95 24 9 −5 −5.40
Left insula 112 −33 21 −1 −5.49
compared to normal subjects (Playford et al., 1992; Rowe et al.,
2002). Compared to normal controls, a significant reduction of
presynaptic dopaminergic markers in the putamen have been
observed in previous reports of EOPD patients (Ribeiro et al.,
2009). In our study comparing ReHo maps between two PD
groups and young or old NCs, we also observed PD-related
pathophysiology and found altered activities in PD that were
mainly focused in the putamen. Our finding of less functional
synchronization of the putamen in EOPD and LOPD patients is
consistent with a previous study on PD using the ReHo method
(Wu et al., 2009a).
EOPD cases had lower dopamine transporter (DAT) binding
in the putamen than did LOPD cases with similar disease
duration (Antonini et al., 2002). In previous studies, although
EOPD patients have shown a lower DAT density, they have
presented similar symptoms of motor disability and PD
severity during the off state (Shih et al., 2007). Consistent
with these studies, we found that no significant difference in
disease severity or disease duration exists between the two
PD groups; however, EOPD patients showed decreased ReHo
values in the right putamen compared to LOPD patients. These
observations suggest that EOPD patients may have more efficient
compensatory mechanisms, which is in alignment with previous
studies (Pavese et al., 2009; de la Fuente-Fernández et al.,
2011). Compensatory mechanisms in the dopaminergic and/or
non-dopaminergic systems, pharmacokinetic adaptations, and
neuronal plasticity might be more effective in EOPD patients
(Shih et al., 2007). The increase in dopamine neuronal loss and
the early neuroplastic compensatory mechanisms might explain
why EOPD patients have less functional synchronization in the
putamen compared to LOPD patients despite similar symptoms
and disease stage. This might be one of the reasons for the
differences shown in several clinical reports (Alves et al., 2005;
Ribeiro et al., 2009). Patients with EOPD tend to exhibit slower
disease progression and respond better to levodopa medications
compared to LOPD patients. Furthermore, we found a significant
negative correlation between the UPDRS total score and ReHo
value within the putamen in LOPD patients that was not
discovered in EOPD patients. Consistent with our results, Wu
et al. have shown that an altered ReHo value in the putamen
correlates with the progress of the disease in elderly PD patients
(Wu et al., 2009a). A PET study has also observed that a
significant negative correlation between DAT in the putamen
and clinical stage, as determined by H&Y staging, was more
markedly observed in an LOPD group compared to an EOPD
group (Nagasawa et al., 1996). We found that the severity of
PD, as measured by the UPDRS total score (and UPDRS Part
III score), was not significantly different between the two patient
groups, although EOPD appeared to have lower spontaneous
activity. This finding is in agreement with those of other studies.
Our results increase the evidence to support that PD-related
changes occur in the putamen and disproportionate putamen
alterations are more prominent in patients with a younger age
of onset. However, whether ReHo could be a predictor of disease
progression and an available marker for underlying disease is
unclear, and needs further investigation.
We found increased ReHo values in the left superior frontal
gyrus in EOPD patients compared to patients with LOPD. The
superior frontal gyrus is thought to be related to feelings of
hate (Zeki and Romaya, 2008) and emotion control. There are
several possible explanations that might underlie our findings.
First, the hyperactivation of this region might be a compensatory
mechanism in EOPD. The altered volume and region activity
in this area may be characteristics changes in patients with
early PD (Long et al., 2012; Yang et al., 2013). The pattern of
hyperactivation in prefrontal cortex in patients with early PD
has been shown to drop progressively over time, and it might
correlate with the progression of the disease (Baglio et al., 2011).
When considered together with our results, hyperactivity in the
superior frontal gyrus might indicate a functional compensation
for a defective basal ganglia. Second, the different patterns of
spontaneous brain activity might reflect a difference in regional
vulnerability across the PD subgroups. The frontal gyrus is
involved in both control of motor processing (Tanei et al.,
2009) and attention to action (Jueptner et al., 1997; Rowe et al.,
2002). The associative circuit in the striatal-thalamo-cortical loop
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FIGURE 2 | Correlation between the mean fitted ReHo index and the
UPDRS score in both EOPD and LOPD patients (P < 0.01,
uncorrected). A negative correlation was discovered between the ReHo
values of the right putamen (x, y, z = 29, 14, 0) and the total UPDRS scores in
LOPD patients (r = –0.67, p < 0.01).
projects from associative cortical areas, such as the prefrontal
cortex, to the caudate nucleus, and the putamen (Baglio et al.,
2011). It is generally accepted that inhibition of the motor
response is principally mediated by the fronto-striatal-thalamic
pathway. The abnormalities of the superior frontal cortex
indicate a selective impairment of the fronto-striatal-thalamic
loop, which is probably due to a reduced level of dopamine
in the basal ganglia (Mink, 1996) or frontal lobes that are
secondary to abnormal basal ganglia outflow. Additionally, the
frontal gyrus appears to be important in cognition and emotion
regulation (Jueptner et al., 1997; Rowe et al., 2002; Phillips et al.,
2003). A previous resting state functional imaging study has
demonstrated that PD is characterized by increased regional
spontaneous neural activity in the frontal area (Luo et al.,
2014). Further, previous clinical investigations have observed
that EOPD patients have higher rates of mood disorder (Schrag
and Schott, 2006). An earlier study by our group on PD
accompanied by depressive symptom (PDD) have observed
significantly increased regional activity in frontal gyrus in PDD
compared with the non-depressed PD patients (Sheng et al.,
2014). When combined with our results, despite we have
excluded the patients with cognitive and emotional disorders in
our study, these findings imply that altered neural activity in the
frontal cortex might be associate with higher rates of depression
in EOPD.
Herein, we also observed that compared with age-matched
control subjects, EOPD patients showed increased ReHo values
in the left inferior temporal gyrus. The dysfunction of the
temporal cortex underlies PD patient difficulty in dealing with
complex sentence structures (Ye et al., 2012). In untreated
PD patients, the earliest pathophysiological changes have been
shown to occur in the subcortical white matter of the temporal
gyrus (Martin et al., 2009). However, while previous studies
have found changes in structure and function in the temporal
gyrus area, age has not been considered as a factor in previous
studies. Thus, more conclusive studies are still needed. Two VBM
studies have observed that temporal lobe atrophy occurs in early-
onset depressive disorders (Greenwald et al., 1997) and in PD
patients with depression (Phillips et al., 2003). When combined
with another clinical study (Mehanna et al., 2014), depression
is more frequent in EOPD patients; therefore the higher
ReHo values in EOPD patients suggest that altered temporal
gyrus activity might be associated with emotion regulation in
EOPD. However, additional studies are needed to confirm these
conclusions.
We also observed that the LOPD group showed significantly
lower ReHo values in the left insula compared with age-matched
control subjects. Previous neuroimaging studies using structural
MRI, fMRI, or PET have observed insula damage in PD patients,
and these patients also exhibited fatigue or dysarthria (Kikuchi
et al., 2001; Stefurak et al., 2003; Pavese et al., 2010). A functional
connectivity study on PD patients has found some regions
that showed positive functional connectivity with the insula,
including the putamen and supplementary motor area (Yu et al.,
2013). These results provide a promising aspect to investigate the
pathophysiological characteristics of LOPD.More studies need to
be conducted to reveal the initial state of ReHo in the insula and
its relevance with respect to age in PD.
Several limitations of the present study deserve to be
mentioned. First, the number of experimental subjects was
relatively small. The small sample size may reduce the
generalizability of our results. Replication of the results with
larger samples will be necessary to establish the reliability of the
differences between the EOPD group and LOPD group. A larger
independent data set will be required to validate the current
findings. Second, it has been shown that L-DOPAmight influence
brain activity over time (Wu et al., 2009b; D’Andrea et al., 2013).
In our study, all patients with PD were assessed after stopping
their medication for 12 h prior to scanning to minimize the
impact of medicine. However, the potentially confounding effects
of the chronic use of dopaminergic medications could not be
avoided herein because an absolute elimination of the influence
of medications was impossible. Additionally, it is known
that head motion can influence results even when traditional
realignment is performed (Power et al., 2012; Satterthwaite et al.,
2013). In the current study, all images were realigned to the first
image to account for headmotion. Any subject was excluded who
had a maximum displacement in any of the cardinal directions
(x, y, z) that was larger than 2 mm or a maximum spin (x, y, z)
that was larger than 2◦. Finally, we noted that the abnormal
activity that was observed in some brain regions of EOPD
and LOPD subjects only demonstrated regional synchronization
changes that were associated with neural spontaneous activity.
However, the functional connectivity and global complex brain
network properties of resting state neural activity remain to be
addressed.
Taken together, our findings support the notion that
age at onset modulates the distribution of cerebral regional
homogeneity in resting state and that disproportionate putamen
alterations are more prominent in PD patients with a younger age
of onset.
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